• Utilization and Evaluation of Delphi Panels In German Amnog Assessments

    Oct 1, 2017, 00:00

  • Quantity And Quality Of External Event Validation Procedures Performed In Published Health Economic Models In Obesity- Outcomes Of A Systematic Review

    Oct 1, 2017, 00:00

  • External Reference Pricing In Greece. A Comparative Analysis For 2015-2017

    Oct 1, 2017, 00:00

  • Early Access To Medicines Pathways – Results Of A Global Survey

    Oct 1, 2017, 00:00

  • The Impact Of Obesity And Deprivation On HRQOL Gains Following Hip And Knee Replacements

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib, Gefitinib, Erlotinib, and Pemetrexed-Based Chemotherapy as First-Line Treatments for Egfr Mutation Positive, Advanced Non-Small Cell Lung Cancer in China

    Oct 1, 2017, 00:00

  • Desarrollo De Material Audiovisual Educativo Basado En La Evidencia Para Promover La Salud Materna Y Neonatal

    Oct 1, 2017, 00:00

  • An Evaluation of the Utilisation and Expenditure on Dual Antiplatelet Therapy (DAPT) in Ireland

    Oct 1, 2017, 00:00

  • Real-World Evaluation Of Physician Attitudes Towards The Prescription Of Androgen Deprivation Therapy For Patients With Prostate Cancer

    Oct 1, 2017, 00:00

  • How To Aggregate Various Values of Medical Devices Innovation?; A Review of Empirical Work

    Oct 1, 2017, 00:00

  • Application of Mixed-Method Study Designs in Health- Economic- Related Studies. A Narrative Review

    Oct 1, 2017, 00:00

  • Cambios En La Calidad De Vida Relacionada Con La Salud De Pacientes Sometidos A Preparación Intestinal

    Oct 1, 2017, 00:00

  • French People With MS And Their Caregivers Have To Financially Support Direct Non-Medical Costs Linked To Their Disease

    Oct 1, 2017, 00:00

  • How does high meld score increases total expenditure on health system? A micro-costing prospective cohort study

    Oct 1, 2017, 00:00

  • Incontinence Control System (Interstim®) for the Fecal Incontinence Treatment at Healthcare Public Sector in Mexico

    Oct 1, 2017, 00:00

  • Resource Use, Health Care Costs And Burden Of Disease In Patients With Polycythemia Vera In Finland- Evaluation Based On Leukocyte Counts Using Finnish Real World Data From Auria Biobank

    Oct 1, 2017, 00:00

  • Predicting Dengue Fever Outbursts In Brazil- An Empirical Model Based On Climatic Parameters

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Alectinib Compared To Chemotherapy for The Treatment of Treatment-Naïve Patients With Alk Positive Locally Advanced or Metastatic Non-Small Cell Lung Cancer (NSCLC) in Greece

    Oct 1, 2017, 00:00

  • Comparing The Methods Of Incorporating The Health Related Quality Of Life Of Advanced Cancer Patients In Economic Models

    Oct 1, 2017, 00:00

  • Distribuição Das Principais Neoplasias Malignas Segundo Sexo E Ano De Diagnóstico, Registro Hospitalar De Câncer, Instituto Do Câncer Do Estado De São Paulo, 2008-2012

    Oct 1, 2017, 00:00

  • Economic Effectiveness Of The Attune® Knee System - Analysis Of Real World Hospital Length Of Stay And Incidence Of Early Complications

    Oct 1, 2017, 00:00

  • Analysis of Real Data for Treatment of Preterm Birth in Pregnant in Ukraine

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Thresholds- Review of Methods

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Threshold in Brazil Through A League-Table Approach- Systematic Review

    Oct 1, 2017, 00:00

  • Health Economic Evaluations in Inflammatory Bowel Disease in Brazil- A Systematic Review

    Oct 1, 2017, 00:00

  • Psychometric Properties Of The EQ-5D-5L In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • Number of Cases Based on The Most Commonly Funded Diseases In Home Special Care In Hungary, 2013

    Oct 1, 2017, 00:00

  • Appropriate Psoriatic Arthritis Treatment is Delayed for Years- Results From a Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Body Piercings- Epidemiological Study on a Representative Sample of 5,000 French Subjects

    Oct 1, 2017, 00:00

  • Mejoramiento De Los Resultados Clínicos En Pacientes Con Reemplazos De Cadera Y Rodilla

    Oct 1, 2017, 00:00

  • Identification of Generic Cancer Medicines That Have Undergone Momentous Price Rises in The Nhs in England

    Oct 1, 2017, 00:00

  • Disease Burden Of Fractures In Patients With Osteoporosis In Japan

    Oct 1, 2017, 00:00

  • A Retrospective Analysis Of Surgery Time For Echo PS™ Positioning System With Ventralight™ St VS Flat Mesh By Size In Outpatient Hospital Laparoscopic Hernia Repair Procedures

    Oct 1, 2017, 00:00

  • Budget Impact of Post-Stroke Dysphagia- Database Analyses of Hospital Discharges In France And Switzerland

    Oct 1, 2017, 00:00

  • Conventional and Biological Therapy in Patients with Rheumatoid Arthritis. A Cost Analysis in Colombia

    Oct 1, 2017, 00:00

  • Possibilities of Domestic Producers of The Republic of Kazakhstan In The Field of Manufacturing Anti-Tuberculosis Medicines

    Oct 1, 2017, 00:00

  • A Path Analysis of Effects of Patients’ Underlying Conditions, Treatment Satisfaction And Adherence on Quality of Life Among Korea Glaucoma Patients- Results From Korea Glaucoma Outcomes Research

    Oct 1, 2017, 00:00

  • Patient-Reported Outcomes In Labels And Package Leaflets Of Drugs Approved By The European Medicines Agency From 2007 To 2017

    Oct 1, 2017, 00:00

  • The Health-Related Quality Of Life (HRQOL) Associated With Ostomy Appliances And Features

    Oct 1, 2017, 00:00

  • Development of A Patient-Reported Questionnaire In Patients With Chronic Pruritus

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Trifluridine/Tipiracil for The Treatment of Metastatic Colorectal Cancer in Portugal

    Oct 1, 2017, 00:00

  • Smoking Cessation Interventions Based on Social Marketing Principles- A Review

    Oct 1, 2017, 00:00

  • Cost-Per-Responder of Fixed Combination Calcipotriol + Betamethasone Dipropionate Aerosol Foam Vs Ointment In Patients With Psoriasis Vulgaris In The UK

    Oct 1, 2017, 00:00

  • Feasibility Of Precision Oncology Virtual Tumor Boards To Optimize Direct Point-Of-Care Management And Clinical Trial Enrollment Of Advanced Cancer Patients

    Oct 1, 2017, 00:00

  • Direct Medical Costs In The Year Of Mortality For Patients With Diabetes- A Population-Based Patient-Level Analysis

    Oct 1, 2017, 00:00

  • Economic Evaluation of A Patient Support Programme Abbvie Care 2.0 Immunology

    Oct 1, 2017, 00:00

  • Potential Mortality Reduction with Optimal Usage of Sacubitril/Valsartan Therapy for the Treatment of Heart Failure in Chile

    Oct 1, 2017, 00:00

  • Impact Of Using External Reference Pricing (ERP) And Health Technology Assessment (HTA) As Part Of Cost-Containment Policies- Comparison Of Prices In Latin America

    Oct 1, 2017, 00:00

  • The UK's Binge Drinking Culture- Losing More Than Just Our Dignity?

    Oct 1, 2017, 00:00

  • Hematopoietic Cell Transplantation Facilities- Geographic Access in Colombia

    Oct 1, 2017, 00:00

  • PROS In Oncology HTA Decisions, Do They Matter?

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Preoperative MRI In Ductal Carcinoma In Situ of The Breast

    Oct 1, 2017, 00:00

  • Evaluation And Development of Habitual Posture And Posture Deemed Correct With Back School Program Among Primary School Children

    Oct 1, 2017, 00:00

  • Open To The Public? A Comparative Analysis Of Data Published Under The “Ema Policy On The Publication Of Clinical Data” And Dossiers For Early Benefit Assessments In Germany

    Oct 1, 2017, 00:00

  • Possible Mistakes During Blood Pressure Measuring- Inappropriate Posture

    Oct 1, 2017, 00:00

  • Costos de la Fibrilación Auricular en Colombia

    Oct 1, 2017, 00:00

  • Developing A Conceptual Modelling Framework For Economic Evaluation

    Oct 1, 2017, 00:00

  • Market Access Trends Across The EU5- 2009 To 2016- An Update

    Oct 1, 2017, 00:00

  • Family Caregiving in Dementia and its Impact on Quality of Life and Economic Burden in Japan – Web-Based Survey

    Oct 1, 2017, 00:00

  • Costs of Major Complications of Type 2 Diabetes- A Systematic Review

    Oct 1, 2017, 00:00

  • Real-World Evidence of Direct-Acting Antivirals Persistence on Planned Hepatitis C Treatment

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Primary HPV Screening With Dual-Stain Cytology Triage In The Cervical Cancer Screening Program Of Belgium

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Tacrolimus As Primary Immunosuppression For Lung Transplant Recipients In The Czech Republic

    Oct 1, 2017, 00:00

  • Modelling The Burden of Cardiovascular Disease In Colombia And The Impact of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Effectiveness Of Lacosamide For The Treatment Of Non-Controlled Focal Epilepsy

    Oct 1, 2017, 00:00

  • The Resource Cost of Switching Stable Rheumatology Patients From An Originator Biologic To A Biosimilar In The UK

    Oct 1, 2017, 00:00

  • Conversion of a French Electronic Medical Record (Emr) Database into the Observational Medical Outcomes Partnership Common Data Model

    Oct 1, 2017, 00:00

  • Zoster Vaccine Effectiveness Against Incident Herpes Zoster and Post-Herpetic Neuralgia In Elderly In The UK

    Oct 1, 2017, 00:00

  • The Introduction Of A Threshold For The Icer And The Implications For Reimbursement Of Drugs In The Dutch Healthcare System

    Oct 1, 2017, 00:00

  • Evidence Map of Costs Studies In Cystic Fibrosis Since 2000

    Oct 1, 2017, 00:00

  • Heart Failure Management- Impact Of A New Health-Care Organisation On Readmissions And Costs

    Oct 1, 2017, 00:00

  • Competencies Of Formal Carers Regarding Basic Clinical And Soft Skills In The Provision Of Outpatient Services And Patients’ Perspective- The Two Sides Of The Same Coin

    Oct 1, 2017, 00:00

  • Cost Consequence Analysis Of Different Gene Mutation Testing Modalities For Braf V600E Mutation In Advanced Non-Small Cell Lung Cancer Using A Decision Analytic Model

    Oct 1, 2017, 00:00

  • Burden Disease of Aortic Stenosis Associated in Patients Undergoing Transcatheter Aortic Valve Replacement

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness Of Tavi In Inoperable And High Risk Patients In France

    Oct 1, 2017, 00:00

  • Economic Evaluation of Subcutaneous Methotrexate For Long-Term Treatment of Moderate-To-Severe Psoriasis In The United Kingdom

    Oct 1, 2017, 00:00

  • The Effect of Perceived Financial Burden of Prescription Co-Payments on Medication Adherence

    Oct 1, 2017, 00:00

  • Value Frameworks For Cancer Care- Do They Account For Potential Durable Survival With Immunotherapy?

    Oct 1, 2017, 00:00

  • Optimal Interval of Endoscopic Screening Based on Stage Distribution of Detected Gastric Cancer

    Oct 1, 2017, 00:00

  • An Updated Review Of The Health Economic Burden Of Varicella In Latin America And The Caribbean

    Oct 1, 2017, 00:00

  • A Model For Alzheimer’s Disease In The Prevention Setting

    Oct 1, 2017, 00:00

  • Economic Burden Of Vaccine Preventable Infectious Diseases Among Elderly Patients In Dutch Hospitals

    Oct 1, 2017, 00:00

  • Cost-Savings Due to The Withdrawing of Biological Therapy for Treatment of Rheumathoid Artritis in A Specialized Center in Colombia

    Oct 1, 2017, 00:00

  • Cost-Utility Analysis Of Antihypertensive Dosage Adjustments By A Pharmacist In A Community Setting

    Oct 1, 2017, 00:00

  • The Multicriteria Decision Analysis Of Using Tetrabenazine For Patients With Hungtington’s Disease In Russia

    Oct 1, 2017, 00:00

  • Budget Impact of IV Iron Therapy with Ferric Carboxymaltose In Patients with Chronic Heart Failure And Iron Deficiency In France

    Oct 1, 2017, 00:00

  • Comparing The Effect of Progressive Relaxation And Perineal Strenghtening Interval Exercises Among Women With Primaer Dysmenorrhoea To Reduce Menstrual Cramps

    Oct 1, 2017, 00:00

  • The Impact of Treatment-Free Remission of Tasigna® for Cml Patients in China – A Cost Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Patient Characteristics And Bleeding Events In Non-Valvular Atrial Fibrillation Patients Treated With Apixaban or Vitamin K Antagonists- Real-World Evidence From Italian Administrative Databases

    Oct 1, 2017, 00:00

  • Pump-Downloaded Insulin Usage For The First 12 Months In A Cohort of Children Newly-Diagnosed With Type 1 Diabetes (T1D)

    Oct 1, 2017, 00:00

  • The Analysis Of Final And Surrogate Effectiveness Criteria Used In Health Economic Studies Of Drugs Submitted Into The Reimbursement In Russia In 2016

    Oct 1, 2017, 00:00

  • Tasas De Hospitalización De Los Pacientes Con Defectos De La Coagulación (Demanda Y Profilaxis) EN UNA Aseguradora Colombiana

    Oct 1, 2017, 00:00

  • Health-Related Quality of Life in Moderate-to-Severe Plaque Psoriasis Patients in Brazil

    Oct 1, 2017, 00:00

  • Geografia Do Gasto Público COM Nefrologia No Brasil 2013 A 2016

    Oct 1, 2017, 00:00

  • Reviewing The Effectiveness of Uk Drug Horizon Scanning Efforts The Production of Nice Commentary Along Therapeutic Specialties

    Oct 1, 2017, 00:00

  • Secukinumab As A More Efficient Alternative For The Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis Versus Adalimumab And Golimumab From A Peruvian Perspective For Private And Public Health Schemes

    Oct 1, 2017, 00:00

  • Understanding Health Technology Assessment Outcomes For Products With Conditional Market Authorisation In Fran Initial Evaluation VS. Re-Assessment

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Painful Diabetic Neuropathy and Postherpetic Neuralgia in Major 5 European Countries, the United States and Japan

    Oct 1, 2017, 00:00

  • Análise De Custo Efetividade Da Toxina Onabotulínica A No Tratamento Preventivo Da Migrânea Crônica

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Incisional Hernia Repairs Considering Poly-4-Hydroxybutyrate Resorbable Meshes

    Oct 1, 2017, 00:00

  • Model Types Submitted To Ni What Is Considered Appropriate By Evidence Review Groups?

    Oct 1, 2017, 00:00

  • Reported Utilities for Patients with Untreated Advanced/Metastatic Renal Cell Carcinoma – A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Early Response To Certolizumab Pegol In Rheumatoid Arthritis Predicts Outcome- Data From A Prospective Observational Study

    Oct 1, 2017, 00:00

  • Forecasting The Potential Public Health Impact of Herpes Zoster Vaccination In Italy

    Oct 1, 2017, 00:00

  • Inclusion Of Safety/ADR-Related Outcomes In Economic Evaluations For Seasonal Influenza Vaccines- A Review Of Available Studies

    Oct 1, 2017, 00:00

  • Unmet Healthcare Needs Due To Financial Reasons In Times Of Austerity

    Oct 1, 2017, 00:00

  • Selecting Software Packages For Conducting Cost-Effectiveness Modelling In Health Care

    Oct 1, 2017, 00:00

  • Heterogeneous Preferences in the Adjunct Drug Treatment of Severe Hypercholesterolemia- A Latent-Class Analysis

    Oct 1, 2017, 00:00

  • Predicting The Future Costs of Cancer Based on Register Data and Innovation Trends

    Oct 1, 2017, 00:00

  • The Association Between Multimorbidity, Socioeconomic Factors, And Multimorbidity-Related Excess Healthcare Use - Results From The 2014 National Health Interview Survey

    Oct 1, 2017, 00:00

  • The Cost of Tiotropium 5MCG + Olodaterol 5MCG In The Management Of Copd In Greece

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ribociclib Plus Letrozole Versus Palbociclib Plus Letrozole for Postmenopausal Women with Hormone Receptor-Positive (HR+), Human Epidermal Growth Factor Receptor 2-Negative (HER2–) Advanced/Metastatic Breast Cancer fro ...

    Oct 1, 2017, 00:00

  • A Cost Per Responder Analysis of Secukinumab Vs. Adalimumab Based on a Matching-Adjusted Indirect Comparison of Efficacy Data for the Treatment of Ankylosing Spondylitis at 52 Weeks from the Irish Payer Perspective

    Oct 1, 2017, 00:00

  • Difficulties In Vaccine Introduction In A Large-Area Country- Meningococcal Vaccination In Russia

    Oct 1, 2017, 00:00

  • Cost Effectiveness Evaluation of Transradial Versus Transfemoral Access For Emergent Percutaneous Coronary Intervention In Patients With St Elevation Myocardial Infarction

    Oct 1, 2017, 00:00

  • Review Of Real-World Evidence To Assess The Burden Of Illness Of Mantle Cell Lymphoma

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Tigecycline In Comparision With Imipenem/Cilastatin Or Piperacillin/Tazobactam In The Treatment Of Complicated Intra-Abdominal Infections- A Perspective Of Iranian Health Systems

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Hemostatic Matrix Pads VS Standard of Care In Cardiac Surgery (Italian Hospital Perspective)

    Oct 1, 2017, 00:00

  • Societal Cost Patterns By Spine Surgical Outcome Groups And Patients Treated With Spinal Cord Stimulation Following Spine Surgery

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Paliperidone Palmitate 3-Monthly for The Treatment of Schizophrenia In Italy

    Oct 1, 2017, 00:00

  • The First Five Months Of National Prescription Monitoring In Finland

    Oct 1, 2017, 00:00

  • Municipal Health Conferences In The State Of Baden-Wuerttemberg, Germany – Ready For Initiating And Steering Primary Health Care Provisions At Community Level?

    Oct 1, 2017, 00:00

  • Adhrence To Routine Medical Screening Among Healthcare Professionals

    Oct 1, 2017, 00:00

  • I-O Optimise- Developing A Unique Multinational Real-World Evidence-Based Research Platform In Oncology

    Oct 1, 2017, 00:00

  • The Effect of Smoking Cessation Interventions in Patients with Copd- A Systematic Review

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of The Use of Daclatasvir + Asunaprevir In The Treatment of Patients With Chronic Hepatitis C in Peru

    Oct 1, 2017, 00:00

  • Measuring Changes In Patterns of Tobacco Product Use Over Time- Transition Probability Approaches

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Afatinib Versus Erlotinib for The Treatment of Squamous Non-Small Cell Lung Cancer in France After A First-Line Platinium Based Therapy

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Comparing Blinatumomab In The Treatment Of Adults With Philadelphia Chromosome-Negative Relapsed or Refractory B-Cell Precursor Acute Lymphoblastic Leukemia (All) With Flag-Ida And Hyper CVAD

    Oct 1, 2017, 00:00

  • Modelling The Burden Of Cardiovascular Disease In Mexico And The Impact Of Reducing Modifiable Risk Factors

    Oct 1, 2017, 00:00

  • Use of New Therapies and Hospital Admission Near the End of Life in Castration Resistant Prostate Cancer (CRPC) in the Castration Resistant Prostate Cancer Registry (CAPRI) in the Netherlands

    Oct 1, 2017, 00:00

  • The Budget Impact of Introducing Demineralised Bone Matrix Combined with Local Bone to Replace Currently Available Treatments for Lumbar Spinal Fusion Procedures in Spain

    Oct 1, 2017, 00:00

  • The Economic Burden of Varicella in Peru

    Oct 1, 2017, 00:00

  • A Systematic Review of The Health-Related Quality of Life and Costs in Diffuse Large B-Cell Lymphoma

    Oct 1, 2017, 00:00

  • Effects Of Availability Of Essential Medicines List On Sellected Domains Of Pharmacy Services In A National Health Insurance Scheme (NHIS) Accredited Pharmacy Of A University Teaching Hospital In Nigeria; An Intervention Study

    Oct 1, 2017, 00:00

  • Treatment Patterns of Chronic Heart Failure (CHF) In Brazil

    Oct 1, 2017, 00:00

  • Concept of Pharmaceutical Care In The Brazilian Legislation

    Oct 1, 2017, 00:00

  • Qualitative Evaluation of Healthcare Provider Trust (And Mistrust) Among Patients with Symptomatic Peripheral Artery Disease

    Oct 1, 2017, 00:00

  • A Comparison Of The Appraisals By The English National Institute For Health And Care Excellence (NICE) For Two Therapies For Relapsed Or Refractory (RR) Chronic Lymphocytic Leukaemia (CLL)- Idelalisib+Rituximab (IR) And Ibrutinib

    Oct 1, 2017, 00:00

  • The Patient-Reported Apnea Questionnaire (PRAQ)- A Prom Optimized For Use On Both Individual Patient And Aggregate Level

    Oct 1, 2017, 00:00

  • Qualitative Exploration of the Real-World Experiences of Men Receiving or Refusing Chemotherapy (Docetaxel) for the Treatment of Metastatic Hormone-Sensitive Prostate Cancer (MHSPC)

    Oct 1, 2017, 00:00

  • Systematic Literature Review Of Economic Evaluations And Healthcare Resource Utilisation Studies In The Treatment Of Clostridium Difficile Infection

    Oct 1, 2017, 00:00

  • Modelling Cardiovascular Outcomes In Type 2 Diabetes In The ERA Of Cardiovascular Outcomes Trials

    Oct 1, 2017, 00:00

  • Incidence of Non-Small-Cell Lung Cancer And Burden of Egfr Mutations- A 10-Year Global Forecast

    Oct 1, 2017, 00:00

  • Burden Of Endometriosis And Related Symptoms In A Nationwide Health Plan With 2 Million Members

    Oct 1, 2017, 00:00

  • Drug Utilization and Pharmacological Costs of Intravitreal Injected Antivegfs in Maculopathies in San Raffaele Hospital

    Oct 1, 2017, 00:00

  • Patient Characteristics, Skeletal Related Events (SRE) And Renal Impairment (RI) In Patients With Multiple Myeloma (MM)- A Patient Chart Audit In EU5

    Oct 1, 2017, 00:00

  • Rasch Measurement Analysis Of The Lower Extremity Functional Scale For Foot And Ankle Patients

    Oct 1, 2017, 00:00

  • Cost –Effectiveness of Obinutuzumab As Frontline Treatment For Unfit Patients With Chronic Lymphocytic Leukemia In Republic of Macedonia

    Oct 1, 2017, 00:00

  • Why Do ‘True’ Orphan Medicines Have Such A Low Acceptance Rate When Assessed By The SMC?

    Oct 1, 2017, 00:00

  • Impact of Spironolactone on Das-28 in Naive Rheumatoid Arthritis Patients

    Oct 1, 2017, 00:00

  • The Implications of Brexit on The UK Nhs and The UK Pharmaceutical Industry

    Oct 1, 2017, 00:00

  • Secukinumab Vs. Adalimumab for Treatment of Ankylosing Spondylitis- A Cost Per Responder Analysis at 52 Weeks from an Argentinian Perspective

    Oct 1, 2017, 00:00

  • Cost Consequence Analysis of Immune-Enhancing Nutritional Formula in Patients with Digestive Cancer Surgery

    Oct 1, 2017, 00:00

  • Comparison of Catheter Ablation Versus Medical Treatment for Paroxysmal Atrial Fibrillation- Healthcare Utilization and Costs Analysis (Preliminary Results)

    Oct 1, 2017, 00:00

  • Can Early Access Support Continued Access? The Relationship Between Eams And Nice

    Oct 1, 2017, 00:00

  • Comparative Study Of Healthcare Resource Utilization (HRU) Outcomes Between Chronic Lymphocytic Leukemia (CLL) Patients Treated With Ibrutinib Versus Non-Ibrutinib Treated Patients

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analisys of Trastuzumab Emtanzine in Patients with Metastatic Breast Cancer and Central Nervous System Metastases

    Oct 1, 2017, 00:00

  • New Drugs Approval In Italy- Analysis Of The Applied Negotiation Conditions 2015-2017

    Oct 1, 2017, 00:00

  • Evaluation of the Cost Saving Potential of Introducing an Etanercept Biosimilar (SB4) for the Treatment of Approved Etanercept Indications in the Republic of Ireland

    Oct 1, 2017, 00:00

  • Pharmacoeconomic Analysis Of Dalbavancin Use In Acute Bacterial Skin And Soft Tissue Infections

    Oct 1, 2017, 00:00

  • Generics Policies- A Systematic Review Of Their Effectiveness

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Brivaracetam As Adjunctive Therapy for Partial-Onset Epilepsy In The Finnish Setting

    Oct 1, 2017, 00:00

  • Real-World Multiple Myeloma Treatment Pattern In Morocco- Evidence From Patient Chart Audit

    Oct 1, 2017, 00:00

  • Drug Utilization Study Of Antibacterial In The Medical Intensive Care Unit (Micu) Of A Chitwan Medical College Teaching Hospital(Cmcth), Bharatpur, Chitwan, Nepal

    Oct 1, 2017, 00:00

  • A Systematic Literature Review Of The Measurement Properties Of Generic Utility Instruments In East And Southeast Asia

    Oct 1, 2017, 00:00

  • Value Of Information Analysis Using Generalized Additive Model Regression- A Case Study In Heart Failure Disease Management

    Oct 1, 2017, 00:00

  • Potential Funding Sources For Breakthrough Therapies

    Oct 1, 2017, 00:00

  • The Role Of General Practitioners In Diagnostic Delay In Case Of Cutaneous Malignant Melanoma Patients

    Oct 1, 2017, 00:00

  • Stigmatisation Level Towards Mental Illness Patients Among Malaysian Urban and Rural Communities

    Oct 1, 2017, 00:00

  • Real World Treatment Patterns of PCSK9 Inhibitors Among Patients with Dyslipidemia in Germany, Spain, and United Kingdom

    Oct 1, 2017, 00:00

  • A Budget Impact Analysis of Fidaxomicin Versus Vancomycin and Metronidazole for the Treatment of Clostridium Difficile

    Oct 1, 2017, 00:00

  • Examining Health Care Utilization and Costs Among Atherosclerosis Patients in the US Veteran Health Administration Population

    Oct 1, 2017, 00:00

  • Disease Burden Mapping In Rare Diseases- An Example of Hypophosphatasia

    Oct 1, 2017, 00:00

  • Treatment for Cervix Uteri Cancer- Cost-Effectiveness Analysis in A Developing Country Context

    Oct 1, 2017, 00:00

  • Assessing Racial Disparity In Palliative Care Consultation And The Impact Of Palliative Care Consultation On Hospi A Multi-Hospital Analysis

    Oct 1, 2017, 00:00

  • Cost-Minimization Analyses of Biological Therapies in the Treatment of Rheumatoid Arthritis from the Egyptian Healthcare System Perspective

    Oct 1, 2017, 00:00

  • Economic Burden Of Household For Treating Severe Pneumonia Among Under Five Children In Bangladesh

    Oct 1, 2017, 00:00

  • Health-Related Quality Of Life And Rates Of Emergency Room Visits And Hospitalization In Patients With Al Amyloidosis- A Prospective Analysis

    Oct 1, 2017, 00:00

  • Orphan Drugs In Fran Key Market Access Incentives

    Oct 1, 2017, 00:00

  • TRENDS AND PREDICTIVE FACTORS OF HRQOL IN TRAUMA PATIENTS. - A PROSPECTIVE COHORT STUDY

    Oct 1, 2017, 00:00

  • NATIONAL POLICY ON HEALTH TECHNOLOGY MANAGEMENT- A CASE STUDY OF THE NATIONAL COMMITTEE FOR TECHNOLOGY INCORPORATION, BRAZIL (CONITEC)

    Oct 1, 2017, 00:00

  • EVidence Synthesis For Health Technology Assessment With Limited Studies

    Oct 1, 2017, 00:00

  • Characteristics and cost burden of adverse drug reactions in a tertiary health care hospital in southern chile

    Oct 1, 2017, 00:00

  • Access to Orphan Drugs (ODS) in Spain Compared with EU4 Countries- Inequity and Lack of Price Transparency Across Europe

    Oct 1, 2017, 00:00

  • Determinantes De La Calidad De Vida Relacionada Con La Salud En Pacientes Con VIH/SIDA EN UNA Aseguradora EN Salud EN Colombia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Posaconazole in Private and Public Brazilian Hospitals

    Oct 1, 2017, 00:00

  • Adapting The United States’ Antimicrobial Stewardship Programme Guidelines To Build An Economic Evaluation Framework For Chinese Hospitals

    Oct 1, 2017, 00:00

  • The Impact Of Systemic Juvenile Idiopathic Arthritis (SJIA) On A Caregiver’s Productivity And The Child’s Schooling

    Oct 1, 2017, 00:00

  • Consumer Comments in Health Technology Assessment in Australia- How Common and Influential Are They?

    Oct 1, 2017, 00:00

  • The Effect Of Nsaids On Myocardial, Vascular And Renal Risk Categories-Systematic Review Of Randomized Controlled Trial And Observational Studies

    Oct 1, 2017, 00:00

  • The Impact of Health Policy on The Pharmaceutical Supply Chain In France

    Oct 1, 2017, 00:00

  • Growth Hormone Pharmacoeconomics and Prescription Data for Children Outpatients in a Regional General Hospital

    Oct 1, 2017, 00:00

  • Trend Analysis of Listing And Budget Impact For Orphan Drugs In Korea

    Oct 1, 2017, 00:00

  • Patient Characteristics and Treatment Patterns in Chronic Heart Failure- Results from a Multinational Real-World Cross Sectional Survey

    Oct 1, 2017, 00:00

  • Impact of Low Adherence On Cost-Effectiveness Of The Biological Treatment of Psoriasis (PSO) And Psoriatic Arthritis (PSA) In Slovenia

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Anaferon® In The Treatment Of Acute Respiratory Infections In Mexico

    Oct 1, 2017, 00:00

  • Burden Of Illness Of Deep Vein Thrombosis In Europe – Mortality And Health Related Quality Of Life

    Oct 1, 2017, 00:00

  • Regional Variations In Appraisal And Uptake Of New Treatments For Ultra Rare Diseases In The UK- A Case Study Of Ataluren For Nonsense Mutation Duchenne Muscular Dystrophy (NMDMD)

    Oct 1, 2017, 00:00

  • Adapting Pharmacoeconomics To Shape Efficient Health Systems En Route To Uhc - A Conceptual Framework

    Oct 1, 2017, 00:00

  • The Relationship Of Predicted Benefits In Life Expectancy And Quality Adjusted Life Expectancy For Improved Glucose Control In Type 2 Diabetes Simulation Modeling

    Oct 1, 2017, 00:00

  • The Effectiveness And Cost-Effectiveness Of Different Methods Of Recruiting Patients To A Pain Study

    Oct 1, 2017, 00:00

  • Incidence and Prevalence of Epilepsy in Germany

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Pcv13 Vs Ppsv23 For The Immunization of Adults Over 65 Years with Low or Moderate Risk of Pneumococcal Infection

    Oct 1, 2017, 00:00

  • Predictors of Early Discontinuation of Interferon-Free Direct Antiviral Agents in Patients With HCV and Advanced Fibrosis- Results of A Real-Life Cohort

    Oct 1, 2017, 00:00

  • Engaging Patients In The Development and Validation of Patient-Reported Outcome (PRO) Measures As Partners, Not Just Participants

    Oct 1, 2017, 00:00

  • Cost Effectiveness of Optifast® LCD As Compared with Liraglutide 3 Mg And “No Intervention” In Switzerland

    Oct 1, 2017, 00:00

  • O Indicative Budget Impact Of Posaconazole Versus Itraconazole In Invasive Fungal Infection Prophylaxis In Adult Patients With Aml/Mds

    Oct 1, 2017, 00:00

  • Secukinumab Vs Adalimumab for the Treatment of Psoriasic Arthritis- a Cost Per Responder Analysis at 48 Weeks from a Peruvian Perspective for Public and Private Health Schemes

    Oct 1, 2017, 00:00

  • How Do Nice Evidence Review Groups Perceive Single Technology Appraisals Presenting Limited Evidence of Comparative Treatment Efficacy?

    Oct 1, 2017, 00:00

  • Direct Oral Anticoagulants Versus Low-Molecular-Weight Heparins for Venous Thromboembolism Prevention Following Total Knee Replacement- Comparative Effectiveness and Medical Costs from a French Nationwide Cohort Study of Around 60,000 Patie ...

    Oct 1, 2017, 00:00

  • Assessing Methodologies For Health State Utilities In Paediatric Indications For Cost-Utility Analyses- Review Of Nice Technology Appraisals For Paediatric Indications

    Oct 1, 2017, 00:00

  • Mobile Cardiac Monitorization Is A Cost-Effective Tool For The Diagnosis And Management Of Atrial Fibrillation Compared To Holter- A Cost Effectiveness Study In Turkey

    Oct 1, 2017, 00:00

  • The Cost Effectiveness of Omalizumab For The Treatment of Severe Allergic Ashtma In Korea

    Oct 1, 2017, 00:00

  • Economic Burden of Immune Thrombocytopenia (ITP) In Patients Receiving Eltrombopag (EPAG) And Romiplostim (ROMI)- Real World Evidence From 26 US Institutions

    Oct 1, 2017, 00:00

  • A Dynamic Decision Analysis Process For Evaluating Pandemic Influenza Intervention Strategies

    Oct 1, 2017, 00:00

  • Difference Between Annual National Health Statistics And 1-Complete-Year Medical Use In Cost-Estimation

    Oct 1, 2017, 00:00

  • Health Care Consumption And HRQOL In Severe Asthma In Sweden

    Oct 1, 2017, 00:00

  • Title- Modelling The Effect of Syphilis Screening At The Entry Point in Chilean Prisons

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis of Sorafenib Versus Best Supportive Care in Patients with Advanced Hepatocellular Carcinoma from Health Care System Perspective in Egypt

    Oct 1, 2017, 00:00

  • Spirometry of Lung Function Evaluation in Stone Crushing Workers Quetta, Pakistan

    Oct 1, 2017, 00:00

  • Mimicking Real Life Decision-Making in Health- Allowing Respondents Time-To-Think in a Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • IS TRANSTHEORETICAL MODEL’S STAGES OF CHANGE A GOOD PREDICTOR OF MEDICATION ADHERENCE IN PATIENTS WITH TYPE 2 DIABETES?

    Oct 1, 2017, 00:00

  • Assessment of Marketed and In-Development Products for Alzheimer’s Disease- What are the Strategic Value Drivers?

    Oct 1, 2017, 00:00

  • Port Catheter Versus Peripherally Inserted Central Catheter For Adjuvant Chemotherapy In Breast Cancer- A Cost-Effectiveness Analysis

    Oct 1, 2017, 00:00

  • Factors Associated With Sustained Smoking After Type 2 Diabetes Diagnosis In Korean Men

    Oct 1, 2017, 00:00

  • Report of Low Density Lipoprotein (LDL) Levels in Patients Diagnosed Whit Hipertension, Diabetes Mellitus and Chronic Kidney Disease in Colombian Population

    Oct 1, 2017, 00:00

  • Opioid Use Outcomes Among Female Breast Cancer Patients Using Adjuvant Endocrine Therapy Regimens

    Oct 1, 2017, 00:00

  • Closing The Evidence Gap For Orphan Drugs- Do German Regulatory Requirements Give Incentives For High Level Evidence Generation?

    Oct 1, 2017, 00:00

  • Access To Medicines- Developing An Indicator To Assess The Impact of Public Policies

    Oct 1, 2017, 00:00

  • Using Convergent Mixed Methods To Evaluate Treatment Risks and Benefits In Rare Disease- An Example From A Phase Ii Registration Trial In Metastatic Merkel Cell Carcinoma

    Oct 1, 2017, 00:00

  • Early Acess But Then What? The Uk Early Access To Medicines Scheme Three Year Report Card

    Oct 1, 2017, 00:00

  • Developing New Practice Model To Ensure Better Medication Concordance

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Ivabradine In The Treatment of Patients With Chronic Heart Failure In Iran

    Oct 1, 2017, 00:00

  • Hepatoprotective Effect Of Herbal Remedy With Anti-Tuberculosis Treatment

    Oct 1, 2017, 00:00

  • The Effectiveness and Cost-Effectiveness of Tobacco Control Mass Media Campaigns In Scotland

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Dabrafenib and Trametinib Combination Therapy in The Treatment of Braf V600e-Mutant Advanced Non-Small Cell Lung Cancer in The United States

    Oct 1, 2017, 00:00

  • The Difference Between Regulatory And Market Access Decisions On Treatment Availability For New Drugs In Six Common Cancers Across Australia, Canada, And Europe

    Oct 1, 2017, 00:00

  • Analysis of Effectiveness Criteria In Pharmacoeconomic Studies of Antimicrobial Therapeutic Agents Proposed for Inclusion In The Essential Drug List (RUSSIA) In 2014-2016

    Oct 1, 2017, 00:00

  • Osteopathic Manipulative Therapy In Patients With Headache- Systematic Literature Review

    Oct 1, 2017, 00:00

  • Mapping From The Bdi-Ii To The EQ-5D-5L Questionnaire In Patients With Major Depression Disorder

    Oct 1, 2017, 00:00

  • A Retrospective Database Analysis of Treatment Pathways And Estimated Costs of Treatment In Metastatic Colorectal Carcinoma (MCRC) In Germany

    Oct 1, 2017, 00:00

  • The Development Of Acute And Chronic Inpatient Bed Capacities In Neurological, Neurosurgical And Psychiatric Professions Between 2002 And 2016 In Hungary

    Oct 1, 2017, 00:00

  • Assessment of Isoniazid Prophylaxis Therapy Initiation Appropriateness, Adverse Drug Reaction and Adherence Among Hiv Patients In University of Gondar Referral Hospital, Northwest Ethiopia

    Oct 1, 2017, 00:00

  • Combined Use of Isoniazid and Rifapentine in The Treatment of Latent Tuberculosis- A Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Factors Associated with an Adherence with Antiepileptic Drugs in Children Treated in Pediatric Practices in Germany

    Oct 1, 2017, 00:00

  • Clinical And Cost Impact of A Novel Non-Invasive Approach For The Treatment of Cervical Dysplasia From A US Payer Perspective

    Oct 1, 2017, 00:00

  • Pharmacoeconomics of Certolizumab Pegol- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Exploring The Association Between Risk Of Bleeding And Comorbid Conditions For Patients With Warfarin Treatment

    Oct 1, 2017, 00:00

  • Modeling Techniques for Fitting Healthcare Resource Use Costs Derived From Patient Reported Counts of Hospital, ER, And PCP Visits

    Oct 1, 2017, 00:00

  • Challenges In Demonstrating Disease-Modifying Effects- Evidence-Based Testing Of A Novel Statistical Approach In Alzheimer’s Disease

    Oct 1, 2017, 00:00

  • Systematic Review on Clinical Outcomes of Ultrasonic Technology For Patients Undergoing Gyn Oncology Procedures

    Oct 1, 2017, 00:00

  • Evaluating Robotreviewer for Automated Risk of Bias Assessment in a Systematic Review- A Case Study

    Oct 1, 2017, 00:00

  • Economic Evaluation Of Neonatal Screening For Congenital Hypothyroidism

    Oct 1, 2017, 00:00

  • Tofacitinib in Adult Patients with Active Rheumatoid Arthritis- Budget Impact Analysis

    Oct 1, 2017, 00:00

  • Clinical Inertia in Type 2 Diabetes Mellitus- Time in Poor Glycaemic Control Until Treatment Intensification in Patients on DPP-4I And/Or SGLT-2I Treatment

    Oct 1, 2017, 00:00

  • Predicting EQ-5D Utility Index Scores for Gastric Cancer Patients in Japan- A Preliminary Model

    Oct 1, 2017, 00:00

  • The Evolution of Nice Medtech Innovation Briefings And Their Associated Technologies

    Oct 1, 2017, 00:00

  • Pharmacoepidemiology of Lateral Amiotrophic Sclerosis in the Republic of Belarus

    Oct 1, 2017, 00:00

  • The Disease Burden of Heart Failure in Portugal

    Oct 1, 2017, 00:00

  • Direct Costs And Healthcare Resource Use Associated With Patients With Hypercholesterolaemia And Established Cardiovascular Disease In Spain

    Oct 1, 2017, 00:00

  • The Cost-Effectiveness of Sacubitril/Valsartan In The Treatment Of Chronic Heart Failure With Reduced Ejection Fraction In Turkey

    Oct 1, 2017, 00:00

  • Development And Psychometric Evaluation Of An Owner-Completed Measure Of Feline Health And Quality Of Life

    Oct 1, 2017, 00:00

  • Mapping the Modified Ashworth Scale and Physician’s Global Assessment to Preference-Based Health Utilities in Adults with Lower Limb Spasticity

    Oct 1, 2017, 00:00

  • Direct Medical Costs Of Hypoglycemia Hospitalizations In The United States

    Oct 1, 2017, 00:00

  • Developing and Piloting A Value Framework and a Tool to Inform the “Evidence-to-Decision Making” Process

    Oct 1, 2017, 00:00

  • Do EU5 Countries with Favourable Healthcare Expenditure and Reimbursement Indicators Have Better Patient-Reported Access to Treatments for Rare Diseases?

    Oct 1, 2017, 00:00

  • Cost-Benefit Analysis of A Smoking Cessation Program Funded By The Spanish National System In Pre-Operative Patients

    Oct 1, 2017, 00:00

  • Bypassing Agents Prophylaxis In Patients With Haemophilia And Inhibitors Undergoing Surgery- A Decision Analysis In Spain

    Oct 1, 2017, 00:00

  • USO De Los Índices De Shannon En La Evaluación Del Poder Discriminante Del EQ-5D Y EL EQ-5D-5L En UNA Muestra De Pacientes Con VIH/SIDA En Colombia

    Oct 1, 2017, 00:00

  • Assessing The Utilization Of Diabetic Non-Small Cell Lung Cancer Patients Compared To Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Specificities of Cancer Immunotherapy – Challenges From Market Access Perspective

    Oct 1, 2017, 00:00

  • Cost Comparison of Licensed Intravitreal Therapies For Diabetic Macular Edema That Responds Insufficiently To Intravitreal Anti-Vegf – A German 3 Year Cost Model

    Oct 1, 2017, 00:00

  • A Framework for the Cost-Effectiveness Analysis of Novel Biomarker Testing in Cardiovascular Disease

    Oct 1, 2017, 00:00

  • Identifying The Primary Outcome For A Randomised Controlled Trial In Rheumatoid Arthritis- The Role of A Discrete Choice Experiment

    Oct 1, 2017, 00:00

  • The Potential Value Of Multiparametric Magnetic Resonance Imaging In Active Surveillance Of Men With Low-Risk Prostate Cancer- A Cost-Effectiveness Modeling Study

    Oct 1, 2017, 00:00

  • Add-On Therapy in Breast Cancer - Probability of Cost-Effectiveness in Economic Analyses

    Oct 1, 2017, 00:00

  • The Patient-Reported Disease Burden In Adults With Atopic Dermatitis- A Cross-Sectional Study In Canada and Europe

    Oct 1, 2017, 00:00

  • Terms Requiring Multiple Translations Or A Descriptive Translation In The Target Language And Vice Versa

    Oct 1, 2017, 00:00

  • Delayed Biologic Switching Among Ankylosing Spondylitis (As) Patients May Result in Poor Health- Related Quality of Life- Results From A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • Estimations of Resource use, Costs, Clinical and Epidemiological Outcomes of Continuous and Intermittent Renal Replacement Therapies

    Oct 1, 2017, 00:00

  • Análisis De Variabilidad En Los Precios De Servicios En Salud Para Colombia

    Oct 1, 2017, 00:00

  • Assessing The Robustness Of Network Meta-Analysis Of Atypical Antipsychotics In The Presence Of Heterogeneity

    Oct 1, 2017, 00:00

  • Identifying Attributes of Cancer Treatments- What Do Stakeholders Consider Important?

    Oct 1, 2017, 00:00

  • The Flow Of EU-28 Country Clusters In Terms Of Infectious And Chronic Diseases During A Refugee Crisis

    Oct 1, 2017, 00:00

  • Implementation Of A Societal Cost-Effective Model Of A Swiss Canton School Vaccination Campaign Through A Hospital Pharmacy Logistics Platform

    Oct 1, 2017, 00:00

  • Pricing Regulation For Generics In Gree The Case Of Atorvastatin

    Oct 1, 2017, 00:00

  • Health Related Quality OF Life Standards in Patients with Parkinson

    Oct 1, 2017, 00:00

  • Translation And Cultural Adaptation Of The Body-Q Chest Module Into Finnish For Use In Gynecomastia, Weight Loss And FTM Chest Surgery

    Oct 1, 2017, 00:00

  • Predicting Quality Adjusted Life Years Using St. George Respiratory Results In Patients With Severe Emphysema Treated with Endobronchial Coils In Addition To Standard of Care Compared To Standard of Care Alone

    Oct 1, 2017, 00:00

  • Why Do People Participate In Health-Related Preference Studies? A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • A Review of Clinical Outcome Assessment Labeling in Europe and in the United States (2013-2016)

    Oct 1, 2017, 00:00

  • Haart Treatment Trends In Hiv/Aids Patients In A Tertiary Care Hospital, Malaysia

    Oct 1, 2017, 00:00

  • Estimating Life Years And Quality-Adjusted Life Years In Heavily Treatment-Experienced (HTE) Patients

    Oct 1, 2017, 00:00

  • Investigation Of Drug Therapy Problems In Type 2 Diabetes Outpatients With Comorbid Hypertension In A Tertiary Hospital In Southeast Nigeria

    Oct 1, 2017, 00:00

  • Budget Impact of A Supra-Ciliary Micro-Stent In Both Stand-Alone Surgery And In Combination With Cataract Surgery For Primary Open-Angle Glaucoma From A UK Secondary Care Perspective

    Oct 1, 2017, 00:00

  • BRCA1/2-Mutated Breast Cancer In Select EU Markets- Incidence, Treatable Populations, And Potential Market Size For Parp Inhibitors

    Oct 1, 2017, 00:00

  • Health Technology Assessment In Singapore- Shining A Light In The Darkness

    Oct 1, 2017, 00:00

  • Clinical Characteristics and Outcome of The Influenza A (H1N1) Patients Admitted to the Tertiary Level Hospital, Peshawar

    Oct 1, 2017, 00:00

  • Different Methods for Modelling Severe Hypoglycaemic Events- Implications for Effectiveness and Cost-Effectiveness Analyses

    Oct 1, 2017, 00:00

  • Risk Sharing Agreements As Payment Mechanisms- A Comprehensive And Communicable Practical Approach For Stakeholders

    Oct 1, 2017, 00:00

  • Misclassification of Diabetes Type I in German Claims Data

    Oct 1, 2017, 00:00

  • Reduction of LDL-C Levels is Most Important - Patient Preferences for Drug Treatment Adjunct to LDL-C Apheresis in Severe Hypercholesterolemia

    Oct 1, 2017, 00:00

  • Validation Of The EQ-5D-5L In Patients With Hip Or Knee Osteoarthritis

    Oct 1, 2017, 00:00

  • Transition From Orphan Disease To Full Assessment In The German Amnog System- Key Learnings From Pioneers

    Oct 1, 2017, 00:00

  • Spatial Dynamics Of Psychiatric Disease Hospitalized Patients - Rehospitalization Simulation Focussing On Diabetes Comorbidity And Regional Health Services In Three European Regions Over The Next Decades

    Oct 1, 2017, 00:00

  • Regional Distribution of The Most Common SPA Services In Hungary In 2014

    Oct 1, 2017, 00:00

  • Epidemiology of BRAFV600-Mutated Metastatic Melanoma In Europe- A Systematic Review

    Oct 1, 2017, 00:00

  • Psychological Impact of Cancer- More Good than Bad

    Oct 1, 2017, 00:00

  • Self-Perceived Health in Latin America- Results from 2007-2008 Gallup World Poll

    Oct 1, 2017, 00:00

  • Secukinumab Shows Higher Symptomatic Improvement and Lower Cost Per Response vs. Adalimumab After One Year Treatment of Active Ankylosing Spondylitis- A Cost Per Responder Analysis from A Chilean Perspective

    Oct 1, 2017, 00:00

  • Adherence To Treatment, Healthcare Resource Use And Costs Related To HIV Patients With Treated With

    Oct 1, 2017, 00:00

  • 6th LAC Abstracts - Financial Disclosure Statements

    Oct 1, 2017, 00:00

  • Cost Consequence of Introducing Paliperidone Palmitate 3-Monthly For The Maintenance Treatment of Schizophrenia In The English National Health Service (NHS)

    Oct 1, 2017, 00:00

  • Validation of a Screening Tool (ICUSI QUESTIONNAIRE) for AF Patients Receiving Vitaminin K Antagonist Therapy

    Oct 1, 2017, 00:00

  • Public Health Expenditure In Patients With Non-Hodgkin's Lymphoma In Mexican Institutions

    Oct 1, 2017, 00:00

  • Estimating The Public Economic Impact Of Different Hepatitis C Healthcare Policies In The Netherlands

    Oct 1, 2017, 00:00

  • Single Armed Observational Data To Closing The Gap In Otherwise Disconnected Evidence Networks

    Oct 1, 2017, 00:00

  • Lessons Learned with Managed Entry Agreements in Portugal

    Oct 1, 2017, 00:00

  • The Comparative Performance of the CHU-9D and Adqol Amongst Children Aged 5 Years or More with Eczema- Evidence from the Clothes Randomised Controlled Trial

    Oct 1, 2017, 00:00

  • Costo De La Inmunización De Rutina En Menores De Un Año En El Año 2016 En El Ecuador

    Oct 1, 2017, 00:00

  • The Study On Expression of Ap-1 Signaling Pathway and Polymorphisms Of Sep15 and Trxr-2 Genes In Kashin-Beck Disease

    Oct 1, 2017, 00:00

  • Economic Burden on families of Children Receiving inpatient Care

    Oct 1, 2017, 00:00

  • Baseline Population Characteristics And The Association Between Progression-Free Survival And Overall Survival In Advanced Non-Small Cell Lung Cancer Patients

    Oct 1, 2017, 00:00

  • Cost Effectiveness Of Contour Curved Cutter Stapler In Low Anterior Resection In Turkey

    Oct 1, 2017, 00:00

  • A Cost-Of-Illness Analysis For Community Acquired Pneumonia In Greece

    Oct 1, 2017, 00:00

  • Does The Presence of An Orphan Drug Polcy Affect HTA Recommendations For Oncologic Orphan Drugs?

    Oct 1, 2017, 00:00

  • Quality-Adjusted Life Year (QALY) Losses Associated With Herpes Zoster And Postherpetic Neuralgia In Immunocompromised (IC) and IC-FREE Individuals AGED ≥50 Years of Age, In The Uk Population

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Obinutuzumab Associated to Chlorambucil for the Treatment of Slow-Go Patients with Chronic Lymphocytic Leukemia (CLL) Under the Brazilian Public Healthcare System

    Oct 1, 2017, 00:00

  • Assessing Criteria for Nice Recommendation With The Hst Programme

    Oct 1, 2017, 00:00

  • Cetuximab in the First-Line Treatment of Ras Wild-Type Metastatic Colorectal Cancer with Liver-Limited Disease

    Oct 1, 2017, 00:00

  • Health and Economic Benefits of Using Single Versus Multiple Inhalers in Patients with Asthma- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • The Importance Of The Disinvestment Process In The Public Health System

    Oct 1, 2017, 00:00

  • Cross Border Reproductive Care- Profile and Incentives of Women Travelling to Greece for IVF Treatment

    Oct 1, 2017, 00:00

  • Characterization Of Low Density Lipoprotein (LDL) Levels In Patients Diagnosed With Cronic Kidney Disease In Colombian Population In The Year 2016

    Oct 1, 2017, 00:00

  • Costs And Life Expectancy Increased Among Patients With Breast Cancer Across Two Time Periods

    Oct 1, 2017, 00:00

  • What Impact Does Nice’s Modified Cancer Drugs Fund Process Mean For Patient Access To New Oncology Pharmaceuticals In England?

    Oct 1, 2017, 00:00

  • Avanços Do Monitoramento Do Horizonte Tecnológico No Brasil

    Oct 1, 2017, 00:00

  • Single Distribution, Two-Part, and Two-Component Finite Mixture Models for Predicting Smoking-Related Indirect Costs In Us Working Adults

    Oct 1, 2017, 00:00

  • Plaque Psoriasis In Bulgaria- Comparative Analysis and Health Technology Assessment

    Oct 1, 2017, 00:00

  • The Cost Of Illness Of Heart Failure In Portugal

    Oct 1, 2017, 00:00

  • Cost Per Response for Abatacept Compared with Adalimumab In the Treatment of Patients with Rheumatoid Arthritis Based on Anti-Citrullinated Protein Antibody Titres In Italy

    Oct 1, 2017, 00:00

  • The Changing Trend of Cardiovascular Disease And Its Clinical Characteristics In Ethiopia-Hospital-Based Observational Study

    Oct 1, 2017, 00:00

  • CYP2C19 Guided Antiplatelet Therapy- A Cost-Effectiveness Analysis of 30-Day and One-Year Outcomes Following Percutaneous Coronary Intervention

    Oct 1, 2017, 00:00

  • Affordability and WTP Challenges of Combinations of High Value/High Priced Products In Oncology – Identifying Solutions for Immunotherapies, Precision Medicines, and Anti-Body Drug Conjugates

    Oct 1, 2017, 00:00

  • Treatment Patterns In Head Neck Squamous Cell Cancer In Fran Artiste Study on Cancerology Patient Charts

    Oct 1, 2017, 00:00

  • One Year Report Card For The Cancer Drugs Fund Reforms – From Absurdity To Irrelevance?

    Oct 1, 2017, 00:00

  • Older Adults’ Views On Incorporating Life Expectancy In Screening Choices – Results From A National Survey Using A Discrete-Choice Experiment

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of P4HB VS Permanent Synthetic Meshes In Complex Abdominal Wall Repair In Spain

    Oct 1, 2017, 00:00

  • Avaliação Da Redução De Rehospitalização Dos Pacientes Com Esquizofrenia, Tratados com Palmitato De Paliperidona

    Oct 1, 2017, 00:00

  • Decision Making Clinical Scenarios As A Tool In HTA Process

    Oct 1, 2017, 00:00

  • Real World Evidence (RWE) on Long-Term Persistence of Fingolimod in Relapsing-Remitting Multiple Sclerosis (RRMS) in Australia

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Vancomycin And Linezolid- A Systematic Literature Review

    Oct 1, 2017, 00:00

  • Lifelong Apixaban Treatment Is Cost-Effective For The Prevention of Venous Thromboembolism In The Netherlands

    Oct 1, 2017, 00:00

  • Budget Impact Of Introducing Ceftazidime-Avibactam (CAZ-AVI) For Complicated Intra-Abdominal Infection (CIAI), Complicated Urinary Tract Infections (CUTI), And Hospital Acquired Pneumonia Including Ventilator-Associated Pneumonia (HAP/VAP) ...

    Oct 1, 2017, 00:00

  • Detrimental Impact of Toxicity on Quality of Life In Hepatocellular Carcinoma Patients Treated with Lenvatinibor Sorafenib

    Oct 1, 2017, 00:00

  • The Cost Study of Cetuximab and Panitumumab in The First-Line Treatment of Mcrc in The Czech Republic

    Oct 1, 2017, 00:00

  • Short-Term Direct And Indirect Cost Burden of Cardiovascular Events In Patients With A History of Atherosclerotic Cardiovascular Disease In The US

    Oct 1, 2017, 00:00

  • The Association Hemoglobin Levels with Health-Related Quality of Life of Patients with Chronic Kidney Disease

    Oct 1, 2017, 00:00

  • Health Insurance Perspective and Collective Perspective- The Differences In The Collection and Valuation of Cost Data In France

    Oct 1, 2017, 00:00

  • Influence of Peer Pressure Mechanism on Quality and Costs of Healthcare, on Examples of Israel, France and USA

    Oct 1, 2017, 00:00

  • A Comparative Review of Value Assessment Frameworks In Germany, France, England, Australia, and South Korea- An Industry Perspective

    Oct 1, 2017, 00:00

  • The Effect Of Epilepsy On The Bulgarian Patients – Pilot Study

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of Ponatinib in The Treatment of Patients With Chronic Phase- Chronic Myeloid Leukemia in Greece

    Oct 1, 2017, 00:00

  • Important Group Differences on the Functional Assessment of Cancer Therapy–Kidney Symptom Index Disease-Related Symptoms (FKSI-DRS) in Patients with Metastatic Renal Cell Carcinoma

    Oct 1, 2017, 00:00

  • Comparative Efficacy And Safety of Olaparib 400 Mg Capsules Bid And Niraparib 300 Mg Tablets QD As Maintenance Treatment After Response To Chemotherapy In Patients with Platinum-Sensitive Relapsed Non-Germline BRCA-Mutated Ovarian Cancer (P ...

    Oct 1, 2017, 00:00

  • Hierarchical Bayesian Model Accounts For Heterogeneity In Oncologists’ Stated Preference On Various Breast Cancer Treatments

    Oct 1, 2017, 00:00

  • Budget Impact Analysis Of Deep Brain Stimulation For The Treatment Of Parkinson’s Disease Patients In The Italian Setting

    Oct 1, 2017, 00:00

  • A Validation Study of The Rank-Preserving Structural Failure Time Model- Confidence Intervals, Unique, Multiple and Erroneous Solutions

    Oct 1, 2017, 00:00

  • Observed Reduction of Healthcare Utilization after Omalizumab Initiation Among Patients with Persistent Asthma Followed in Canadian Clinical Settings

    Oct 1, 2017, 00:00

  • Statin Cost Effectiveness- A Systematic Review Including The Recent Literature

    Oct 1, 2017, 00:00

  • Clinical and Economic History of The Oncological Patient At The End of Life

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis Of Two Long-Acting Muscarinic Antagonists For Copd Treatment In Spain- Umeclidinium VS. Tiotropium (HO-17-18472)

    Oct 1, 2017, 00:00

  • Analysis Of Pharmacy Claims For High Cost Drugs- Ruxolitinib Utilisation And Expenditure In Ireland

    Oct 1, 2017, 00:00

  • Access And Reimbursement For Emerging Neuropathic Pain Agents In The EU5- Avoiding The Sting Of Low-Cost Competition And Tightening Budgets

    Oct 1, 2017, 00:00

  • Budget Impact of The Inclusion of Oxycodone In The Brazilian Public Healthcare Setting For The Treatment of Cancer Pain

    Oct 1, 2017, 00:00

  • Cost Effectiveness Analysis (CEA) of Nivolumab in 2nd Line Non-Small Cell Lung Cancer (NSCLC) with Non-Squamous Histology (NSQ) Using A Mixed Comparator of Docetaxel and Pemetrexed in An Australian Setting

    Oct 1, 2017, 00:00

  • Compras De Medicamentos Sem Licitação No Instituto Nacional De Câncer Do Brasil

    Oct 1, 2017, 00:00

  • Cost Utility Analysis (CUA) of Nivolumab Compared To Everolimus for The Treatment of Metastatic Renal Cell Carcinoma (RCC) in Australia

    Oct 1, 2017, 00:00

  • Landscape of Malignant Melanoma- The Impact of Upcoming Therapies

    Oct 1, 2017, 00:00

  • Impact of Ocrelizumab Vs. Interferon Beta-1a In Delaying The Deterioration Of Patients' Daily Functions and Associated Costs In Relapsing-Remitting Multiple Sclerosis

    Oct 1, 2017, 00:00

  • Cost-Effectiveness Analysis of Apixaban And Rivaroxaban For Treatment of Acute Venous Thromboembolism In China

    Oct 1, 2017, 00:00

  • Real-World Utilization Of Blinatumomab In Acute Lymphoblastic Leukemia In The US

    Oct 1, 2017, 00:00

  • Cost-Effectiveness of A Physical Activity Promotion Intervention For People With Disabilities- A Markov Model Approach

    Oct 1, 2017, 00:00

  • Bisphosphonates for Osteoporosis Treatment- A Cost-Effectiveness Analysis in Vietnamese Woman

    Oct 1, 2017, 00:00

  • Health Insurance Cost of Psychotic Disorders In Hungary- A Cost of Illness Study

    Oct 1, 2017, 00:00

  • Budget Impact Analysis of Avelumab in Patients with Metastatic Merkel Cell Carcinoma in The US

    Oct 1, 2017, 00:00

  • Effect of Vitamins in Prevention of Alzheimer’s Development- A Meta-Analysis of Randomized Controlled Trials

    Oct 1, 2017, 00:00

  • Association Of Multiple Chronic Conditions With Health-Related Quality Of Life And Physical Functioning

    Oct 1, 2017, 00:00

  • Effects of Low Salt Diet on Gene Expression in Dog Heart

    Oct 1, 2017, 00:00

  • The Role Of Medical Technologies In Revolutionising The NHS In England- A Review Of Sustainability And Transformation Plans (STPS)

    Oct 1, 2017, 00:00

  • Interrupted Time Series Analysis Evaluating The Impact of A Pro-Generic Policy on Drug Pricing and Utilization In Argentina

    Oct 1, 2017, 00:00

  • Relapsing-Remitting Multiple Sclerosis Patients On Dimethyl Fumarate Reported Less Physical And Psychological Disease Impact In The Real World Compared With Patients On Platform Therapies

    Oct 1, 2017, 00:00

  • The Implementation Of Robotic-Assisted Surgery For Endometrial Cancer In The United States Lead To An Improvement Of Overall 30-Day Surgical Outcomes Without Increasing Costs- Is Technology Finally Allowing The Diffusion Of Minimally Invasi ...

    Oct 1, 2017, 00:00

  • Launching Combination Therapies In Rare Diseases- Is High Cost Burden Restricting Access?

    Oct 1, 2017, 00:00

  • Ankylosing Spondylitis Limits Patients’ Ability to Contribute to Society As Part of the Workfor Results from A Multi-National Survey Including Latin America

    Oct 1, 2017, 00:00

  • The Relationship of Quality of Life and Complete Psoriasis Clearance Over Time – Analyses From Brodalumab Trial Datasets

    Oct 1, 2017, 00:00

  • Will Prioritization of Vaccine Introduction Lead to a Higher Return of Investment? The Case of Colombia

    Oct 1, 2017, 00:00

  • Use of Brentuximab Vedotin to Treat Hodgkin Lymphoma in a Private Sector Setting in Brazil

    Oct 1, 2017, 00:00

  • Sensitive Skin In Fran Updated Epidemiological Data

    Oct 1, 2017, 00:00
  • «
  • 61
  • 62
  • 63
  • 64
  • 65
  • 66
  • 67
  • 68
  • 69 (current)
  • 70
  • »